Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1287.67	562.10	40.51
Graham Fair Price	-65.72	19.96	58.23
PEG	-6377.92	-0.41	< 0.005
Price/Book	19.53	0.87	0.73
Price/Cash Flow	74.24	-42.56	-165.25
Prices/Earnings	877.62	45.32	-4.64
Price/Sales	32.97	18.12	13.63
Price/FCF	74.24	-42.56	-165.25
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-60.70	0.31	0.78
Operating Margin	-68.24	-0.18	0.58
ROA	-88.22	< 0.005	-0.02
ROE	-0.04	< 0.005	-87.77
ROIC	< 0.005	< 0.005	34.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.02	253.43
Dividends QOQ	< 0.005	-0.01	132.98
EBIT QOQ	77.22	-1.28	-98.34
EPS QOQ	-7.41	1.12	-84.91
FCF QOQ	-2.00	-3.58	-79.23
Revenue QOQ	0.22	-0.11	-49.34
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-64.97	-35.52	45.33
Days Sales Outstanding (DSO)	131.81	152.74	15.88
Inventory Turnover	-1.39	-2.53	-82.91
Debt/Capitalization	0.51	0.53	5.12
Quick Ratio	0.74	0.68	-9.17
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	61.87	60.66	-1.96
Cash	5.40	5.12	-5.28
Capex	-1.03	-0.86	16.29
Free Cash Flow	-0.27	-1.24	-354.92
Revenue	3.31	2.92	-11.87
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.74	0.69	-7.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	23.75	316.77	1233.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating